Found: 8
Select item for more details and to access through your institution.
Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical Models.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 5013, doi. 10.3390/cancers13195013
- By:
- Publication type:
- Article
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders.
- Published in:
- American Journal on Addictions, 2023, v. 32, n. 1, p. 24, doi. 10.1111/ajad.13346
- By:
- Publication type:
- Article
Real-World Evaluation of Clinical Response and Long-Term Healthcare Resource Utilization Patterns Following Treatment with a Digital Therapeutic for Chronic Insomnia.
- Published in:
- ClinicoEconomics & Outcomes Research, 2022, v. 14, p. 537, doi. 10.2147/CEOR.S368780
- By:
- Publication type:
- Article
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder.
- Published in:
- ClinicoEconomics & Outcomes Research, 2021, v. 13, p. 909, doi. 10.2147/CEOR.S334274
- By:
- Publication type:
- Article
Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study.
- Published in:
- JMIR Research Protocols, 2023, v. 12, n. 1, p. 778, doi. 10.2196/43122
- By:
- Publication type:
- Article
Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial.
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 1, p. 1, doi. 10.2196/32759
- By:
- Publication type:
- Article